Credit Suisse Ag Generation Bio Co. Transaction History

Credit Suisse Ag

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$3.66 - $6.77 $1,237 - $2,288	-338 Reduced 1.1%	30,495 $119,000
Q3 2022 Nov 10, 2022	BUY	$4.68 - $8.34 $1,062 - $1,893	227 Added 0.74%	30,833 $164,000
Q2 2022 Aug 12, 2022	BUY	$4.87 - $9.41 $20,132 - $38,900	4,134 Added 15.62%	30,606 $201,000
Q1 2022 May 16, 2022	BUY	$4.16 - $7.76 $6,319 - $11,787	1,519 Added 6.09%	26,472 $195,000
Q4 2021 Feb 14, 2022	BUY	$5.99 - $24.97 $5,031 - $20,974	840 Added 3.48%	24,953 $177,000
Q3 2021 Nov 12, 2021	BUY	$20.0 - $27.43 $27,840 - $38,182	1,392 Added 6.13%	24,113 $605,000
Q2 2021 Aug 16, 2021	BUY	$24.34 - $38.34 $4,089 - $6,441	168 Added 0.74%	22,721 $611,000
Q1 2021 May 14, 2021	BUY	$24.74 - $40.2 $37,110 - $60,300	1,500 Added 7.12%	22,553 $641,000
Q4 2020 Feb 12, 2021	BUY	$21.68 - $51.61 $456,429 - $1.09 Million	21,053 New	21,053 $597,000

49.6M

Ticker GBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,011,200
Market Cap $80.8M
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.